Finance and markets: business, quotes, gold, energy and releases.
Found 5547 articles
Chevron has finalized a technology-licensing deal with ZL Chemicals, granting the supply firm rights to commercialize proprietary surfactants designed for unconventional reservoirs. This partnership aims to scale the oil giant's chemical recovery methods, transitioning them from laboratory development into turnkey field services for shale and tight-oil operators.
Shares of Satellos Bioscience climbed 16% to $9.49 following positive clinical results for SAT-3247, an experimental treatment for Duchenne muscular dystrophy. The company’s stock has now gained 61% since January, reflecting growing investor confidence in its approach to degenerative muscle disease therapy.
Investors pushed FuelCell Energy shares down 13% on Wednesday following news that the company upsized its public offering to $225 million. The stock, which hit $22.60 in recent trading, is recalibrating after a meteoric 328% surge over the past year, as the market digests the influx of 10.7 million new shares.
An arbitration tribunal has cleared the path for Prime Medicine to advance its PM647 treatment for alpha-1 antitrypsin deficiency, ruling the drug falls squarely within the company's rights under its 2019 agreement with Beam Therapeutics. The decision shields Prime from potential claims and clears a critical regulatory hurdle for the firm.
Unexpectedly reversing an eleven-week trend of consistent declines, U.S. crude oil stockpiles climbed by 3 million barrels for the week ending July 3. The Energy Information Administration reported that inventory levels reached 411.4 million barrels, defying analyst expectations of a 1.4 million barrel draw during the same period.
A renewed escalation in the Strait of Hormuz has sent travel stocks into a tailspin, with major U.S. airlines and cruise operators shedding between 1% and 3% in early morning trading after President Trump declared the fragile ceasefire with Tehran officially dead.
As Clarke moves to integrate a significant commercial real estate portfolio, the Canadian firm has overhauled its executive team, elevating finance chief Tom Casey to the role of president. The move signals a strategic shift to sharpen operational oversight across the company’s diverse residential, hotel, and commercial real estate holdings.
The Department of Veterans Affairs has awarded CACI International a six-year, $308 million contract to overhaul its aging financial infrastructure. The defense contractor will transition the agency’s legacy systems to a modernized enterprise resource planning platform designed to streamline accounting, procurement, and reporting processes across the federal department.
Endeavour Silver reported a 31% increase in consolidated silver production to 1.94 million ounces for the second quarter, yet the company fell short of its internal output targets. The growth was largely driven by contributions from the Kolpa mine, offsetting significant operational declines at its long-standing Mexican assets.
A 5.6% jump in premarket trading greeted Palladyne AI on Wednesday as the defense and industrial technology firm reported a sharp increase in preliminary quarterly revenue. The stock, which had already climbed 26% year-to-date, responded to figures that significantly outpaced the expectations set by Wall Street analysts.
Four completed drill holes have already confirmed mineralization, prompting IsoEnergy to resume its summer exploration campaign at the Larocque East uranium project. The Canadian firm mobilized its team back to the eastern Athabasca Basin site this week, moving past a brief evacuation triggered by encroaching northern Saskatchewan wildfires.
Brent crude futures spiked 5% to $73.93 a barrel Wednesday after President Trump signaled the collapse of the mid-June ceasefire with Iran. Speaking at a NATO summit in Ankara, Trump dismissed ongoing diplomatic efforts, labeling Iranian leadership as dishonest while citing renewed vessel attacks in the Strait of Hormuz.
The U.S. Food and Drug Administration is reviewing Arcutis Biotherapeutics’ application to expand the use of its Zoryve topical cream to infants as young as three months old. The agency has set a target action date of February 23, 2027, for the treatment of mild to moderate atopic dermatitis.
Canadian Prime Minister Mark Carney committed on Wednesday to provide a detailed roadmap for national defense financing in this autumn’s budget update. Speaking from Ankara during a NATO summit, Carney faced mounting pressure to explain how Ottawa will fund an ambitious military buildup, including a massive new submarine acquisition.
Shares of Douglas Elliman tumbled 12% to $1.71 in premarket trading Wednesday as the real estate firm announced a sweeping digital overhaul. The company plans to consolidate its workflows under a new intelligence-focused subsidiary named Elius, aiming to reclaim data control and modernize operations through a partnership with Google Cloud.
The Canadian military is moving to secure its northern frontier, reaching an agreement in principle for Telesat’s Lightspeed satellite network to provide protected Ka-band communications across the Arctic. This strategic initiative aims to modernize defense capabilities as the country pushes to meet long-term NATO spending benchmarks.
Critical Metals has appointed advisors to conduct a comprehensive strategic review of its portfolio, signaling an aggressive pivot toward its Tanbreez rare earth project in Greenland. The company is actively weighing asset sales, spin-offs, and joint ventures to streamline operations and unlock value from its non-core holdings.
Consumer products firm Helen of Troy posted a $35.8 million net profit for the first quarter, a sharp reversal from the massive $450.7 million loss reported during the same period last year. The results, fueled by growth in both its Home and Outdoor and Beauty and Wellness segments, easily outpaced analyst projections.
Dallas-based energy firm HF Sinclair has elevated Steven Ledbetter to president and chief operating officer, marking a significant step in the company’s efforts to stabilize its executive suite following a turbulent spring that saw the departure of its top leadership team.
A sweeping leadership shuffle at Ovid Therapeutics has placed Charles Carter in the role of chief financial officer, signaling a shift in the biopharmaceutical firm’s internal structure as it looks toward its next phase of development. The changes involve multiple internal promotions and a strategic new hire.
International Medication Systems, a subsidiary of Amphastar Pharmaceuticals, faces federal scrutiny following a warning letter from the Food and Drug Administration. The agency identified specific violations of current good manufacturing practices at the company’s South El Monte, California plant, prompting an immediate internal remediation effort from the firm.
A 73% surge in processed ore at the Kainantu gold mine has propelled K92 Mining to its most productive second quarter on record. The Canadian miner reported 46,093 gold equivalent ounces for the period, marking a significant leap from the 34,816 ounces produced during the same window last year.
Two-thirds of GameStop shareholders voted on Wednesday to authorize a significant expansion of the company’s share count, clearing the path for the retailer to increase its total stock capacity to 2.5 billion. The decision marks a major shift for the firm, which previously held roughly 451 million shares outstanding.
European regulators are gauging industry reaction to a settlement proposal from Sanofi, which seeks to close an antitrust investigation into the company’s marketing tactics. The healthcare giant faces scrutiny over allegations that it systematically disparaged a rival flu vaccine to protect the market dominance of its own product, Efluelda.
Investors pushed Rivian Automotive shares down another 4.4% to $15.76 in Wednesday premarket trading, extending a sharp sell-off that began Tuesday. The decline follows the electric vehicle maker's decision to price a $1.2 billion public offering at $15.50 per share, deepening concerns over the company's capital strategy.
A sharp divergence hit Asian markets on Wednesday as Hong Kong’s Hang Seng Tech Index climbed 5.0% while South Korea’s Kospi plunged 5.3%, officially entering a bear market after dropping 23% from its recent peak. This reversal marks a tactical migration of capital away from crowded artificial intelligence trades.
The Paris Court of Appeal ruled today that Vincent Bolloré and Bolloré SE do not exercise legal control over Vivendi SE, ending a prolonged judicial dispute over corporate governance. The decision aligns with a directive from the Cour de cassation, which previously identified errors in earlier interpretations of the French Commercial Code.
A 14% decline in net profit to 42 billion yen is expected for Seven & I Holdings when the retail giant reports its first-quarter results this Thursday. Analysts point to a broader contraction in revenue as the company grapples with volatile fuel prices and shifting consumer sentiment in a complex geopolitical environment.
A 23% slide from June’s peak has pushed South Korea’s benchmark Kospi into bear market territory, as a brutal selloff in heavyweight semiconductor stocks wiped out 5.3% of the index’s value on Wednesday. The crash forced the Korea Exchange to trigger emergency trading halts to stem the bleeding.
A 9.1% slide in London-listed shares greeted Vistry on Tuesday as the house builder reported a 30 million pound first-half pretax loss. The downturn, which marks a sharp reversal from last year's 40.9 million pound profit, arrives alongside news that Chief Financial Officer Tim Lawlor is stepping down.